Bank of America’s Redhill Biopharma RDHL Stock Holding History

Bank of America’s Portfolio RDHL Stock Details RDHL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-303	Closed	-$312	–	6642
2025 Q4	$312	Hold	303	–	–	﹤0.01%	6636
2025 Q3	$658	Hold	303	–	–	﹤0.01%	7540
2025 Q2	$588	Hold	303	–	–	﹤0.01%	7638
2025 Q1	$806	Buy	303 +301	+15,050%	+$1.4K	﹤0.01%	7457
2024 Q4	$12	Hold	2	–	–	﹤0.01%	8080
2024 Q3	$17	Sell	2 -3	-60%	-$30	﹤0.01%	7990
2024 Q2	$49	Sell	5 -2	-29%	-$22	﹤0.01%	7839
2024 Q1	$96	Buy	7 +4	+133%	+$71	﹤0.01%	7400
2023 Q4	$120	Buy	3 +2	+200%	+$41	﹤0.01%	7398
2023 Q3	$16	Hold	1	–	–	﹤0.01%	7590
2023 Q2	$38	Hold	1	–	–	﹤0.01%	7482
2023 Q1	$131	Hold	1	–	–	﹤0.01%	7466
2022 Q4	$183	Sell	1 -4	-80%	-$1.73K	﹤0.01%	7558
2022 Q3	$3K	Buy	5 +4	+400%	+$3.48K	﹤0.01%	7520
2022 Q2	$1K	Sell	1 -1	-50%	-$1.37K	﹤0.01%	7884
2022 Q1	$5K	Hold	2	–	–	﹤0.01%	7902
2021 Q4	$5K	Sell	2 -13	-87%	-$52K	﹤0.01%	7834
2021 Q3	$69K	Buy	15 +7	+88%	+$47.5K	﹤0.01%	6898
2021 Q2	$54K	Sell	8 -10	-56%	-$69K	﹤0.01%	6800
2021 Q1	$136K	Buy	18 +15	+500%	+$126K	﹤0.01%	6266
2020 Q4	$26K	Sell	3 -6	-67%	-$53.9K	﹤0.01%	6527
2020 Q3	$96K	Buy	9 +4	+80%	+$32.8K	﹤0.01%	5729
2020 Q2	$35K	Buy	5 +2	+67%	+$13.8K	﹤0.01%	6114
2020 Q1	$14K	Hold	3	–	–	﹤0.01%	6269
2019 Q4	$18K	Hold	3	–	–	﹤0.01%	6528
2019 Q3	$21K	Hold	3	–	–	﹤0.01%	6576
2019 Q2	$20K	Hold	3	–	–	﹤0.01%	6569
2019 Q1	$25K	Hold	3	–	–	﹤0.01%	6438
2018 Q4	$17K	Hold	3	–	–	﹤0.01%	6524
2018 Q3	$26K	Buy	3 +2	+200%	+$16.3K	﹤0.01%	6429
2018 Q2	$9K	Hold	1	–	–	﹤0.01%	6688
2018 Q1	$5K	Sell	1 -2	-67%	-$11.5K	﹤0.01%	6765
2017 Q4	$16K	Hold	3	–	–	﹤0.01%	6491
2017 Q3	$35K	Buy	3 +2	+200%	+$17.8K	﹤0.01%	6086
2017 Q2	$9K	Hold	1	–	–	﹤0.01%	6458
2017 Q1	$10K	Sell	1 -1	-50%	-$9.99K	﹤0.01%	6540
2016 Q4	$16K	Buy	2 +1	+100%	+$12K	﹤0.01%	6426
2016 Q3	$14K	Hold	1	–	–	﹤0.01%	6265
2016 Q2	$11K	Hold	1	–	–	﹤0.01%	6458
2016 Q1	$12K	Hold	1	–	–	﹤0.01%	6335
2015 Q4	$13K	Hold	1	–	–	﹤0.01%	6590
2015 Q3	$13K	Hold	1	–	–	﹤0.01%	6478
2015 Q2	$18K	Hold	1	–	–	﹤0.01%	6373
2015 Q1	$15K	Hold	1	–	–	﹤0.01%	6164
2014 Q4	$13K	Hold	1	–	–	﹤0.01%	6970
2014 Q3	$13K	Hold	1	–	–	﹤0.01%	7239
2014 Q2	$17K	Buy	+1	New	+$15.9K	﹤0.01%	7241

Other funds holding RDHL

YAG

Yorkville Advisors Global Mountainside, New Jersey $86.2M AUM 41.28% 1-Year Est. Return

Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

StoneX Group New York $2.48B AUM 33.54% 1-Year Est. Return

TSS

Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

RhumbLine Advisers Boston, Massachusetts $133B AUM 43.5% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $32.7B AUM 35.71% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Bank of America's RDHL Position: Q1 2026 in Review

Bank of America sold out of Redhill Biopharma (RDHL) in Q1 2026, closing a stake of 303 shares — an estimated $312 sold.

Bank of America first reported a position in RDHL in Q2 2014 and held it in 47 quarters. The position peaked at $136K in Q1 2021. 16 funds tracked by Wall St. Rank hold RDHL as of Q1 2026.

Bank of America reported no remaining Redhill Biopharma position as of Q1 2026 after selling out during the quarter.
Bank of America sold 303 Redhill Biopharma shares in Q1 2026, an estimated $312.
Bank of America first reported a position in Redhill Biopharma in Q2 2014 and held it in 47 quarters.
Bank of America's Redhill Biopharma position peaked at $136K in Q1 2021.
16 funds tracked by Wall St. Rank held Redhill Biopharma as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.